Open access
Aug 2026
Baseline proteomic biomarkers for predicting chemotherapy-induced cardiotoxicity in breast cancer patients
Currently, there are no reliable biomarkers to identify patients at high risk of treatment-related cardiotoxicity before initiation of chemotherapy. The aim of this study was to identify biomarkers for predicting asymptomatic decrease in left ventricular ejection fraction (LVEF) after doxorubicin (DOX)-based chem...
Li-Rong Yu, Zhijun Cao, Dong Wang et al.
· Cardio-Oncology · 0 citations